ASX - By Stock
|
ATH |
Re:
Ann: Webcast Today - New Data from bioMUSE Natural History Study
|
|
johnmartin
|
72 |
22K |
1 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
72
|
22K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Presentation to Extraordinary General Meeting
|
|
johnmartin
|
6 |
2.7K |
6 |
31/12/23 |
31/12/23 |
ASX - By Stock
|
6
|
2.7K
|
6
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity Therapeutics Raises $4.8M AUD in Placement
|
|
johnmartin
|
23 |
9.4K |
8 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
23
|
9.4K
|
8
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
johnmartin
|
5 |
1.6K |
3 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
5
|
1.6K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Sidney up 14%, NY down 17%
|
|
johnmartin
|
4 |
1.4K |
1 |
17/10/23 |
17/10/23 |
ASX - By Stock
|
4
|
1.4K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Ann: First Patient Enrolled in Australia in global Phase 2 Trial
|
|
johnmartin
|
19 |
5.0K |
4 |
16/05/23 |
16/05/23 |
ASX - By Stock
|
19
|
5.0K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Ann: First Patient Enrolled in Australia in global Phase 2 Trial
|
|
johnmartin
|
19 |
5.0K |
1 |
16/05/23 |
16/05/23 |
ASX - By Stock
|
19
|
5.0K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Brain Volume Loss Caused by Anti-β-Amyloid Drugs
|
|
johnmartin
|
2 |
1.0K |
0 |
29/03/23 |
29/03/23 |
ASX - By Stock
|
2
|
1.0K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Dementia, new indication for ATHxxx?
|
|
johnmartin
|
8 |
3.6K |
5 |
10/01/23 |
10/01/23 |
ASX - By Stock
|
8
|
3.6K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
The Fund invested in BioVersys AG
|
|
johnmartin
|
5 |
1.8K |
3 |
06/01/23 |
06/01/23 |
ASX - By Stock
|
5
|
1.8K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
New all time low is looming
|
|
johnmartin
|
33 |
12K |
6 |
23/12/22 |
23/12/22 |
ASX - By Stock
|
33
|
12K
|
6
|
|
ASX - By Stock
|
PV1 |
Re:
Ann: Notification of cessation of securities - PV1
|
|
johnmartin
|
6 |
2.1K |
0 |
19/12/22 |
19/12/22 |
ASX - By Stock
|
6
|
2.1K
|
0
|
|
ASX - By Stock
|
PV1 |
Re:
Ann: Notification of cessation of securities - PV1
|
|
johnmartin
|
6 |
2.1K |
0 |
19/12/22 |
19/12/22 |
ASX - By Stock
|
6
|
2.1K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Antibiotic Resistance Market worth $18.34 Billion by 2030
|
|
johnmartin
|
5 |
2.6K |
3 |
17/12/22 |
17/12/22 |
ASX - By Stock
|
5
|
2.6K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Somebody invested US$ 3
|
|
johnmartin
|
6 |
2.1K |
1 |
24/11/22 |
24/11/22 |
ASX - By Stock
|
6
|
2.1K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Change in substantial holding
|
|
johnmartin
|
26 |
8.1K |
6 |
01/11/22 |
01/11/22 |
ASX - By Stock
|
26
|
8.1K
|
6
|
|
ASX - By Stock
|
ATH |
Re:
The shares issued on the 21st of September
|
|
johnmartin
|
11 |
4.6K |
3 |
14/10/22 |
14/10/22 |
ASX - By Stock
|
11
|
4.6K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
The shares issued on the 21st of September
|
|
johnmartin
|
11 |
4.6K |
0 |
14/10/22 |
14/10/22 |
ASX - By Stock
|
11
|
4.6K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Proposed issue of securities - ATH
|
|
johnmartin
|
24 |
9.7K |
4 |
22/09/22 |
22/09/22 |
ASX - By Stock
|
24
|
9.7K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Ann: US FDA Approval for IND Application for ATH434 for MSA
|
|
johnmartin
|
13 |
7.3K |
2 |
21/09/22 |
21/09/22 |
ASX - By Stock
|
13
|
7.3K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
something is going on for pbt2
|
|
johnmartin
|
7 |
3.0K |
0 |
16/07/22 |
16/07/22 |
ASX - By Stock
|
7
|
3.0K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
ATH Chart Thread
|
|
johnmartin
|
14 |
4.0K |
2 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
14
|
4.0K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
announcement on PBT2
|
|
johnmartin
|
20 |
5.1K |
2 |
27/06/22 |
27/06/22 |
ASX - By Stock
|
20
|
5.1K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
announcement on PBT2
|
|
johnmartin
|
20 |
5.1K |
0 |
27/06/22 |
27/06/22 |
ASX - By Stock
|
20
|
5.1K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
announcement on PBT2
|
|
johnmartin
|
20 |
5.1K |
3 |
26/06/22 |
26/06/22 |
ASX - By Stock
|
20
|
5.1K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
announcement on PBT2
|
|
johnmartin
|
20 |
5.1K |
2 |
26/06/22 |
26/06/22 |
ASX - By Stock
|
20
|
5.1K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity to Present at Life Sciences Investor Forum
|
|
johnmartin
|
21 |
7.1K |
1 |
24/06/22 |
24/06/22 |
ASX - By Stock
|
21
|
7.1K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
BNY Mellon Investment Management on the top 20
|
|
johnmartin
|
15 |
4.1K |
2 |
23/06/22 |
23/06/22 |
ASX - By Stock
|
15
|
4.1K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
BNY Mellon Investment Management on the top 20
|
|
johnmartin
|
15 |
4.1K |
0 |
23/06/22 |
23/06/22 |
ASX - By Stock
|
15
|
4.1K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
BNY Mellon Investment Management on the top 20
|
|
johnmartin
|
15 |
4.1K |
2 |
23/06/22 |
23/06/22 |
ASX - By Stock
|
15
|
4.1K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
BNY Mellon Investment Management on the top 20
|
|
johnmartin
|
15 |
4.1K |
2 |
23/06/22 |
23/06/22 |
ASX - By Stock
|
15
|
4.1K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity Launches ATH434 Phase 2 Clinical Trial
|
|
johnmartin
|
12 |
5.2K |
2 |
02/06/22 |
02/06/22 |
ASX - By Stock
|
12
|
5.2K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity Launches ATH434 Phase 2 Clinical Trial
|
|
johnmartin
|
12 |
5.2K |
2 |
02/06/22 |
02/06/22 |
ASX - By Stock
|
12
|
5.2K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Role of iron in aging related diseases
|
|
johnmartin
|
3 |
1.2K |
0 |
01/06/22 |
01/06/22 |
ASX - By Stock
|
3
|
1.2K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
NASDEC
|
|
johnmartin
|
3 |
1.0K |
0 |
25/05/22 |
25/05/22 |
ASX - By Stock
|
3
|
1.0K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Shorts down to 619K
|
|
johnmartin
|
2 |
765 |
2 |
10/02/22 |
10/02/22 |
ASX - By Stock
|
2
|
765
|
2
|
|
ASX - General
|
|
Re:
The NEXT RECESSION
|
|
johnmartin
|
19 |
5.5K |
2 |
27/01/22 |
27/01/22 |
ASX - General
|
19
|
5.5K
|
2
|
|
ASX - General
|
|
Re:
The NEXT RECESSION
|
|
johnmartin
|
19 |
5.5K |
0 |
27/01/22 |
27/01/22 |
ASX - General
|
19
|
5.5K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Big increase in the number of shorted shares
|
|
johnmartin
|
7 |
2.1K |
4 |
27/01/22 |
27/01/22 |
ASX - By Stock
|
7
|
2.1K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
How to get started with PBT2 deal???
|
|
johnmartin
|
18 |
5.8K |
1 |
13/01/22 |
13/01/22 |
ASX - By Stock
|
18
|
5.8K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Ann: New Data Advance ATH434 as Neurodegeneration treatment
|
|
johnmartin
|
26 |
7.3K |
3 |
06/11/21 |
06/11/21 |
ASX - By Stock
|
26
|
7.3K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Ann: New Data Advance ATH434 as Neurodegeneration treatment
|
|
johnmartin
|
26 |
7.3K |
2 |
06/11/21 |
06/11/21 |
ASX - By Stock
|
26
|
7.3K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Ann: New Data Advance ATH434 as Neurodegeneration treatment
|
|
johnmartin
|
26 |
7.3K |
4 |
06/11/21 |
06/11/21 |
ASX - By Stock
|
26
|
7.3K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Ann: New Data Advance ATH434 as Neurodegeneration treatment
|
|
johnmartin
|
26 |
7.3K |
3 |
05/11/21 |
05/11/21 |
ASX - By Stock
|
26
|
7.3K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Antibiotic-resistant problem: Urgent, serious and concerns of CDC (USA)
|
|
johnmartin
|
12 |
3.4K |
3 |
03/11/21 |
03/11/21 |
ASX - By Stock
|
12
|
3.4K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Today's Endpoints News Lead Article Regarding Eli Lilly Actions and Plans
|
|
johnmartin
|
27 |
9.4K |
3 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
27
|
9.4K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Today's Endpoints News Lead Article Regarding Eli Lilly Actions and Plans
|
|
johnmartin
|
27 |
9.4K |
2 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
27
|
9.4K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Today's Endpoints News Lead Article Regarding Eli Lilly Actions and Plans
|
|
johnmartin
|
27 |
9.4K |
2 |
31/08/21 |
31/08/21 |
ASX - By Stock
|
27
|
9.4K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
NEW PAPER about ATH434 and endothelial cells !!!!
|
|
johnmartin
|
19 |
6.5K |
8 |
01/08/21 |
01/08/21 |
ASX - By Stock
|
19
|
6.5K
|
8
|
|
ASX - By Stock
|
ATH |
Re:
NEW PAPER about ATH434 and endothelial cells !!!!
|
|
johnmartin
|
19 |
6.5K |
7 |
01/08/21 |
01/08/21 |
ASX - By Stock
|
19
|
6.5K
|
7
|
|